LGND News Today: Stay Updated with the Latest Ligand Pharmaceuticals Incorporated News in Real Time
Find LGND news now at Meyka AI. Stay informed with the latest Ligand Pharmaceuticals Incorporated stocks updates, including price news, market analysis, and expert insights.
FTSE 100 Rises 0.85% as US-Iran Deal Hopes Boost Risk Sentiment Despite UK GDP Dip
The FTSE 100 index rose by 0.85% in recent trading sessions as investor sentiment improved following renewed hopes of a potential diplomatic agreement between the United States and Iran. The positive global mood helped offset weaker economic data from the United Kingdom, where GDP figures showed a slight dip. The movement in the FTSE 100…
FDA Issues Alert: 6,408 Cases (160,200 lbs) of Farm Rich Pizza Snack Recalled Over Possible Metal Contamination
The FDA officially flagged a serious metal contamination risk on June 9, 2026. Rich Products Corp voluntarily recalled 6,408 cases totaling 160,200 pounds of Farm Rich Pizza Cheese Crunchers after the products were found to potentially contain metal pieces. Rich Products Corporation is a Buffalo, New York-based company and the maker of the Farm Rich…
Japan Postal Reform Law Advances: ¥65 Billion Support Package, June 12
Japan’s postal privatization law revised with 65 billion yen annual government support for rural post offices. First major update since 2012.
Alembic Pharmaceuticals Shares Jump 3% After US FDA Tentatively Approves Larotrectinib Capsules
Alembic Pharmaceuticals shares rose nearly 3% in trading after the company announced that the US Food and Drug Administration (FDA) granted tentative approval for its Larotrectinib capsules. The development marks a positive milestone for the Indian pharmaceutical company as it continues to expand its presence in the regulated US market. The announcement triggered strong investor…
Bologna Max Bakery Files for Bankruptcy on June 11 After Boom Ends
Bologna Max, a luxury Danish bread maker in Saga, Japan, ceased operations with 410 million yen debt due to pandemic and inflation pressures.
Parabilis Medicines Targets Up to $2.3 Billion Valuation in Expanded U.S. IPO Amid Biotech Market Rally
Parabilis Medicines is aiming for a valuation of nearly $2.3 billion through an expanded U.S. initial public offering, highlighting renewed investor confidence in the biotechnology sector. The Cambridge, Massachusetts-based company increased the size of its offering as demand for biotech IPOs continues to improve following a challenging period for the industry. The company now plans…
Top 5 Stock Gainers YoY in India: VIAANINDUS, EASTSILK, SPYL Deliver Up to 2979% Returns
India’s stock market has produced some of the most striking year-over-year gains anywhere in the world, and the stock gainers list for 2025 to 2026 proves it. Five stocks, Viaan Industries, Eastern Silk Industries, Shekhawati Poly-Yarn, Garodia Chemicals, and iStreet Network, have delivered returns ranging from 834% to nearly 3000% over the past twelve months….
Panacea Biotec Soars 11.89% to 52-Week High After Launch of EU-Funded DENSTAR Project
Panacea Biotec is having its best week in years. The stock surged 11.89% to a fresh 52-week high of ₹619.05 on June 9, 2026, on the NSE, rallying from a 52-week low of ₹293.10, for an 111% climb in under twelve months. The trigger was the official launch of the DENSTAR project, a 48-month, EU-backed…
South Korea Cabinet Approves Decree for $350 Billion U.S. Investment Plan
South Korea has taken a major step in implementing its $350 billion investment commitment to the United States after the Cabinet approved a presidential decree on June 9, 2026. The decision creates the legal framework needed to launch one of the largest overseas investment programs ever backed by Seoul. The package includes $200 billion for…